GlassScriptPhysician profile
Erin E Follen
NPI 1255683595
$2,756.54
in general payments reported to CMS, 2019-2025
14 companies · $960 in 2025
The $960 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $15.93 · 2021: $78.26 · 2022: $217 · 2023: $367 · 2024: $731 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $926.98 | 2019-2025 | Dailies Total1, Precision7, Total30 |
| Bausch & Lomb Americas INC. | $324.56 | 2023-2025 | Infuse, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $305.71 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $214.69 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $209.90 | 2020-2025 | Cequa |
| Coopervision INC. | $179.04 | 2022-2025 | Myday Contact Lens |
| Rxsight INC | $136.34 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Vision Care, INC. | $122.37 | 2019-2024 | |
| Shire North American Group INC | $113.91 | 2019 | |
| Glaukos Corporation | $91.95 | 2025 | Idosetr, Istent Infinite |
| Novartis Pharmaceuticals Corporation | $73.06 | 2021-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $26.16 | 2019 | |
| Biotissue Holdings INC. | $18.10 | 2019 | |
| Kala Pharmaceuticals, INC. | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Follen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.